TGThe Guardian·1wHealth
score-0.75
FDA Updates Warning Labels on GLP-1 Medications to Include Information on Rare Eye Condition Risk
Original
FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications
“High-arousal negative framing emphasizing a severe, irreversible health outcome (blindness) and regulatory warning.”